Babazono T, Kapor-Drezgic J, Dlugosz J A, Whiteside C
Juvenile Diabetes Foundation/Medical Research Council of Canada Group in Diabetic Nephropathy, Department of Medicine, University of Toronto, Ontario.
Diabetes. 1998 Apr;47(4):668-76. doi: 10.2337/diabetes.47.4.668.
Protein kinase C (PKC) is implicated in the pathogenesis of diabetic nephropathy. This study was designed to identify the expression of diacylglycerol (DAG)-sensitive PKC-alpha, -betaII, -delta, and -epsilon isoforms in normal and diabetic rat glomerular cells and to determine the effects of high glucose and insulin on PKC isoform cellular compartmentalization and PKC activity. Diabetic rats treated with or without insulin and normal rats were examined 2 and 4 weeks after streptozotocin/vehicle injection. Renal cortical tissue immunogold-labeled with anti-PKC-alpha, -betaII, -delta, or -epsilon antibody was visualized by electron microscopy. From isolated glomeruli, total cell lysate and cytosol and membrane fractions were immunoblotted with the same anti-PKC isoform antibodies. PKC activity in isolated glomeruli was measured by 32P-phosphorylation of the epidermal growth factor (EGF)-receptor substrate. Immunogold labeling revealed expression of the four PKC isoforms by glomerular visceral epithelial, endothelial, and mesangial cells of both normal and diabetic rats. Immunoblot analysis of the diabetic rat glomeruli at 2 weeks demonstrated a significant increase in membrane-associated PKC-alpha, -delta, and -epsilon and a significant decrease in membrane PKC-betaII content compared with normal, which were similar at 4 weeks. Insulin treatment normalized membrane PKC isoform contents and caused a significant decrease in the cytosol content of PKC-alpha, -betaII, and -delta and total cellular PKC-alpha compared with normal. Although PKC activity in the cells of diabetic rat glomeruli was increased by 20% compared with normal, the difference did not reach statistical significance. In insulin-treated diabetic rat glomeruli, PKC activity was significantly decreased compared with non-insulin-treated diabetic rat glomeruli. In conclusion, DAG-sensitive PKC-alpha, -betaII, -delta, and -epsilon isoforms are all found in the three major glomerular cell types in rats, and the expression, compartmentalization, and activity are modulated independently by high glucose and insulin.
蛋白激酶C(PKC)与糖尿病肾病的发病机制有关。本研究旨在确定二酰基甘油(DAG)敏感的PKC-α、-βII、-δ和-ε亚型在正常和糖尿病大鼠肾小球细胞中的表达,并确定高糖和胰岛素对PKC亚型细胞区室化及PKC活性的影响。在链脲佐菌素/赋形剂注射后2周和4周,对接受或未接受胰岛素治疗的糖尿病大鼠及正常大鼠进行检查。用抗PKC-α、-βII、-δ或-ε抗体进行免疫金标记的肾皮质组织,通过电子显微镜观察。从分离的肾小球中,用相同的抗PKC亚型抗体对总细胞裂解物、细胞溶质和膜部分进行免疫印迹分析。通过表皮生长因子(EGF)受体底物的32P磷酸化来测量分离肾小球中的PKC活性。免疫金标记显示正常和糖尿病大鼠的肾小球脏层上皮细胞、内皮细胞和系膜细胞均表达这四种PKC亚型。与正常大鼠相比,糖尿病大鼠肾小球在2周时的免疫印迹分析显示,膜相关的PKC-α、-δ和-ε显著增加,膜PKC-βII含量显著降低,4周时情况相似。与正常大鼠相比,胰岛素治疗使膜PKC亚型含量正常化,并导致PKC-α、-βII和-δ的细胞溶质含量以及总细胞PKC-α显著降低。虽然糖尿病大鼠肾小球细胞中的PKC活性与正常大鼠相比增加了20%,但差异未达到统计学意义。在胰岛素治疗的糖尿病大鼠肾小球中,与未接受胰岛素治疗的糖尿病大鼠肾小球相比,PKC活性显著降低。总之,DAG敏感的PKC-α、-βII、-δ和-ε亚型在大鼠的三种主要肾小球细胞类型中均有发现,其表达、区室化和活性受高糖和胰岛素独立调节。